NCT05669664 2025-11-10Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland CancersNational Cancer Institute (NCI)Phase 2 Active not recruiting21 enrolled
NCT06145308 2025-09-15Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular TypingPeking Union Medical CollegePhase 2 Recruiting39 enrolled